Chronic Pediatric Skin Conditions
Conditions
Brief summary
This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.
Detailed description
This is a multi center study with Northwestern University/Lurie Children's Hospital serving as the Data Coordinating Center. Site selection has been completed through members of PeDRA.
Interventions
None listed
Sponsors
Pediatric Dermatology Research Alliancce
Regeneron Pharmaceuticals
Immunex Corporation
Northwestern University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
8 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
* Subjects must be aged 8-17 years of age * Subject must be diagnosed with a chronic skin disease deemed to be severe enough and/or in a visible location that could be stigmatizing as determined by the study doctor * Subject and parent must both be English speaking with at least one parent/guardian who will complete the questionnaires * Subject and Parent/Guardian must be able to complete the relevant questionnaires
Exclusion criteria
* Children under 8 years of age * Children with developmental delay and/or a behavioral disorder that would preclude participation in form completion * Children with a non-cutaneous disorder that is considered by the Study doctor to be stigmatizing
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Measure the stigma experienced by children as a function of the child's perceived skin lesion visibility using the altered Neuro-QoL stigma tool | Past 7 days | Measure the stigma experienced by children as a function of the child's perceived skin lesion visibility using the altered Neuro-QoL stigma tool |
Countries
United States
Outcome results
None listed